Michael Dawson's most recent trade in Palisade Bio Inc was a trade of 15,000 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on March 29, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Palisade Bio Inc | Michael Dawson | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.14 per share. | 29 Mar 2022 | 15,000 | 15,000 | - | 1.1 | 17,093 | Common Stock |
| Palisade Bio Inc | Michael Dawson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 32,400 | 32,400 | - | - | Stock Option (right to buy) | |
| Palisade Bio Inc | Michael Dawson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 20,391 | 20,391 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Michael Dawson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 5,438 | 5,438 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Michael Dawson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 5,084 | 5,084 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Michael Dawson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 2,800 | 2,800 | - | - | Stock Option (Right to Buy) | |
| Palisade Bio Inc | Michael Dawson | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 1,962 | 1,962 | - | - | Stock Option (Right to Buy) |